Literature DB >> 6298479

Experimental coxsackie B viral myocarditis in cynomolgus monkeys.

T Hoshino, C Kawai, M Tokuda.   

Abstract

In 11 of 13 cynomolgus monkeys inoculated with coxsackievirus B3 and/or B4, myocarditis was proved histologically. Myocarditis was evident the first 10 days after inoculation and left chronic sequelae; moderate myocardial cellular hypertrophy with an increase of connective tissue with focal distribution, and some residual inflammatory foci were found 5 months after viral inoculation. Virus was recovered from the heart on the 4th day but not on the 10th day, while serum neutralizing antibody rose significantly over 2 or 3 weeks in most of the inoculated monkeys. Electrocardiographic abnormalities were found in all 11 monkeys in which the myocarditis was proved histologically. These abnormalities were usually transient and were detected most often in the ST-T segment of the right-side chest leads, corresponding to the anatomical distribution of the myocarditis.

Entities:  

Mesh:

Year:  1983        PMID: 6298479     DOI: 10.1253/jcj.47.59

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  4 in total

Review 1.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.

Authors:  H Zhang; G E Yousef; X Ouyang; L C Archard
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

3.  Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins.

Authors:  Stephanie J Bissel; Caitlin C Winkler; Joseph DelTondo; Guoji Wang; Karl Williams; Clayton A Wiley
Journal:  Neuropathology       Date:  2014-04-07       Impact factor: 1.906

4.  Myocarditis, disseminated infection, and early viral persistence following experimental coxsackievirus B infection of cynomolgus monkeys.

Authors:  Cheryl E Cammock; Nancy J Halnon; Jill Skoczylas; James Blanchard; Rudolf Bohm; Christopher J Miller; Chi Lai; Paul A Krogstad
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.